Skip to content

TELEMS: Feasibility of Remote Patient Visits in MS

TELE MS RCT: A Randomized Controlled Trial to Evaluate Feasibility of Remote Patient Visits in People With Multiple Sclerosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04838990
Acronym
TELEMSRCT
Enrollment
45
Registered
2021-04-09
Start date
2020-11-01
Completion date
2021-10-01
Last updated
2022-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Keywords

multiple sclerosis, remote visits, telemedicine, remote patient monitoring, remote monitoring

Brief summary

This trials randomizes patients with multiple sclerosis (MS, pwMS) to a remote visit (via phone or videochat) or a regular outpatient visit. Outcomes include satisfaction on the patients' and doctor's side.

Interventions

OTHEREDSS

Neurological Exam - EDSS (Expanded Disability Status Scale)

OTHERDiscussion of symptoms, Patient reported outcome (MSIS)

Patients will be asked about their wellbeing

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
16 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* confirmed diagnosis of any type of MS * own a phone/smartphone/computer * informed consent

Exclusion criteria

* language barriers

Design outcomes

Primary

MeasureTime frameDescription
TMPQ1 week after interventionTelemedicine Perception questionnaire (17-85, higher scores are better)

Secondary

MeasureTime frameDescription
PPSM1 week after interventionPatient and Physician Satisfaction with monitoring (6-30, higher scores are better)

Other

MeasureTime frameDescription
Ancillary Analysesimmediately after the interventionSubgroup analyses comparing scores on the TMPQ above and below the median (Telemedicine Perception questionnaire, 17-85 points, higher scores are better) with clinical characteristics (EDSS and MSIS and Age)
Empirical Questionnaire1 week after interventionParticipants are given an opportunity to openly provide feedback

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026